Dashboard
Manage Tickers

CGTX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/15/2025 17:06:06

reported-earlier-cognition-therapeutics-reports-zervimesine-ct1812-results-in-phase-2-shimmer-dlb-shine-alzheimers--magnify-dry-amd-studies-moving-toward-phase-3-trials
Reported Earlier: Cognition Therapeutics R...
09/15/2025 15:53:10

https://www.sec.gov/Archives/edgar/data/1455365/000110465925089737/tm2525997d1_ex99-1.htm

cognition-therapeutics-2-start-study-of-in-early-alzheimers-disease-reaches-75-enrollment-target
Cognition Therapeutics 2 'START' Study Of ...
09/03/2025 11:31:19

cognition-therapeutics-closes-30m-registered-direct-offering-of-147m-shares-at-205share
Cognition Therapeutics Closes $30M Registe...
09/02/2025 20:01:54

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/28/2025 12:08:20

why-snowflake-shares-are-trading-higher-by-14-here-are-20-stocks-moving-premarket
Why Snowflake Shares Are Trading Higher By...
08/28/2025 09:48:22

reported-earlier-cognition-therapeutics-secures-30m-from-registered-direct-offering-made-to-two-fundamental-institutional-investors
Reported Earlier, Cognition Therapeutics S...
08/28/2025 06:39:46

- The offering was made to two new fundamental institutional investors -- The Company intends to use the net proceeds to fund p...

cognition-therapeutics-regains-compliance-with-nasdaq
Cognition Therapeutics Regains Compliance ...
08/26/2025 20:01:13

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/26/2025 17:06:55

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/22/2025 17:06:29

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/14/2025 17:06:18

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 12:08:29

why-sapiens-international-shares-are-trading-higher-by-around-44-here-are-20-stocks-moving-premarket
Why Sapiens International Shares Are Tradi...
08/13/2025 11:17:43

Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday...

cognition-therapeutics-surges-30-pre-market-after-fda-backs-phase-3-trial-design-for-alzheimers-drug
Cognition Therapeutics Surges 30% Pre-Mark...
08/13/2025 08:55:04

Cognition Therapeutics shares rose 30% pre-market after the FDA confirmed its Phase 3 trial for Alzheimer's drug Zervimesine.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 21:07:08

cognition-therapeutics-aligns-with-fda-on-phase-3-design-for-alzheimers-drug-zervimesine-paving-way-for-nda-filing
Cognition Therapeutics Aligns With FDA On ...
08/12/2025 20:03:23

- Cognition and FDA align on enriched population, study design, and endpoints -PURCHASE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -...

chardan-capital-maintains-buy-on-cognition-therapeutics-maintains-4-price-target
Chardan Capital Maintains Buy on Cognition...
08/08/2025 12:07:46

Chardan Capital analyst Daniil Gataulin maintains Cognition Therapeutics (NASDAQ:CGTX) with a Buy and maintains $4 price tar...

cognition-therapeutics-q2-eps-011-inline
Cognition Therapeutics Q2 EPS $(0.11), Inline
08/07/2025 20:10:35

Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. T...

cognition-therapeutics-presents-results-from-phase-2-cog1201-shimmer-study-of-zervimesine-in-dementia-with-lewy-bodies-at-aaic-2025
Cognition Therapeutics Presents Results Fr...
07/29/2025 11:38:53

- Zervimesine's impact on debilitating DLB behavioral symptoms highlighted in podium presentation -- Plasma p-tau217 levels...

cognition-therapeutics-publishes-results-of-proteomics-analysis-from-phase-2-sequel-cog0202-study-of-zervimesine-in-adults-with-mild-to-moderate-alzheimers-disease
Cognition Therapeutics Publishes Results O...
07/21/2025 11:36:56

Cognition Therapeutics, Inc., (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical-stage company developing...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION